Antidiabetic bicyclic compounds

C - Chemistry – Metallurgy – 07 – D

Patent

Rate now

  [ 0.00 ] – not rated yet Voters 0   Comments 0

Details

C07D 413/04 (2006.01) A61K 31/435 (2006.01) A61K 31/47 (2006.01) A61P 3/10 (2006.01) C07D 215/20 (2006.01) C07D 413/14 (2006.01) C07D 417/04 (2006.01) C07D 417/14 (2006.01)

Patent

CA 2593788

Bicyclic compounds containing a fused pyridine ring, including pharmaceutically acceptable salts and prodrugs thereof, are agonists of G- protein coupled receptor 40 (GPR40) and are useful as therapeutic compounds, particularly in the treatment of Type 2 diabetes mellitus, and of conditions that are often associated with this disease, including obesity and lipid disorders, such as mixed or diabetic dyslipidemia, hyperlipidemia, hypercholesterolemia, and hypertriglyceridemia.

L'invention concerne des composés bicycliques contenant un noyau pyridine fusionné, y compris les sels et promédicaments pharmaceutiquement acceptables de celui-ci, qui sont des agonistes du récepteur couplé aux protéines G 40 (GPR40) et qui sont utiles comme composés thérapeutiques, en particulier dans le traitement du diabète sucré de type 2, et d'états souvent associés à cette maladie, y compris l'obésité et les troubles lipidiques, tels que la dyslipidémie mixte ou diabétique, l'hyperlipidémie, l'hypercholestérolémie, et l'hypertriglycéridémie.

LandOfFree

Say what you really think

Search LandOfFree.com for Canadian inventors and patents. Rate them and share your experience with other people.

Rating

Antidiabetic bicyclic compounds does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Antidiabetic bicyclic compounds, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Antidiabetic bicyclic compounds will most certainly appreciate the feedback.

Rate now

     

Profile ID: LFCA-PAI-O-2065123

  Search
All data on this website is collected from public sources. Our data reflects the most accurate information available at the time of publication.